NTLA · Intellia Therapeutics, Inc. · Documents
$11.84
+0.26 (+2.25%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$1.62B
Shares
140.13M
Volume · Oct 20
3.41M
Avg daily vol (3M)
4.33M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2021-11-04 | — | |
| 10-Q | — | 2021-11-04 | 2021-09-30 | |
| 10-Q | — | 2021-08-05 | 2021-06-30 | |
| 8-K | — | 2021-08-05 | — | |
| 8-K | — | 2021-07-02 | 2021-06-29 | |
| 8-K | — | 2021-06-28 | 2021-06-26 | |
| 8-K | — | 2021-06-24 | 2021-06-23 | |
| 8-K | — | 2021-06-22 | 2021-06-21 | |
| 8-K | — | 2021-06-17 | 2021-06-14 | |
| 8-K | — | 2021-05-06 | — | |
| 10-Q | — | 2021-05-06 | 2021-03-31 | |
| DEF 14A | — | 2021-04-28 | 2021-06-23 | |
| 8-K | — | 2021-04-12 | 2021-04-09 | |
| 10-K | — | 2021-02-26 | 2020-12-31 | |
| 8-K | — | 2021-02-25 | — | |
| 8-K | — | 2021-01-07 | — | |
| 8-K | — | 2020-12-02 | 2020-12-01 | |
| 8-K | — | 2020-11-09 | — | |
| 8-K | — | 2020-11-05 | — | |
| 10-Q | — | 2020-11-05 | 2020-09-30 | |
| 8-K | — | 2020-10-19 | — | |
| 8-K | — | 2020-10-05 | 2020-10-02 | |
| 8-K | — | 2020-08-06 | — | |
| 10-Q | — | 2020-08-06 | 2020-06-30 | |
| 8-K | — | 2020-06-19 | 2020-06-18 | |
| 8-K | — | 2020-06-03 | 2020-06-01 | |
| 8-K | — | 2020-06-01 | 2020-05-30 | |
| 10-Q | — | 2020-05-07 | 2020-03-31 | |
| 8-K | — | 2020-05-07 | — | |
| DEF 14A | — | 2020-04-24 | 2020-06-18 | |
| 8-K | — | 2020-04-09 | 2020-04-03 | |
| 8-K | — | 2020-03-26 | — | |
| 8-K | — | 2020-03-13 | 2020-03-12 | |
| 8-K | — | 2020-02-27 | — | |
| 10-K | — | 2020-02-27 | 2019-12-31 | |
| 8-K | — | 2020-01-09 | — |
Showing 101–136 of 136 filings
Key facts
CIK
1652130
CUSIP
45826J105
13F (30d)
32 filings
28 filers
Visit website
Investor relations